Synonyms: | |
Status: | Approved (2002) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N06AB10 |
UNII: | 4O4S742ANY |
InChI Key | WSEQXVZVJXJVFP-FQEVSTJZSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H21FN2O |
Molecular Weight | 324.4 |
AlogP | 3.81 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 36.26 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 24.0 |
Primary Target | |
---|---|
SERT |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
5100-5800 | 2-4600 | 3 | 1-7879 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Depressive Disorder | 4 | D003866 | ClinicalTrials |
Bipolar Disorder | 3 | D001714 | ClinicalTrials |
Anxiety Disorders | 3 | D001008 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Obsessive-Compulsive Disorder | 3 | D009771 | ClinicalTrials |
Anxiety | 3 | D001007 | ClinicalTrials |
Carcinoma | 3 | D002277 | ClinicalTrials |
Schizophrenia | 3 | D012559 | ClinicalTrials |
Dementia | 3 | D003704 | ClinicalTrials |
Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
Hypertension, Pulmonary | 3 | D006976 | ClinicalTrials |
Bipolar Disorder | 3 | D001714 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Panic Disorder | 2 | D016584 | ClinicalTrials |
Phobic Disorders | 2 | D010698 | ClinicalTrials |
Phobia, Social | 2 | D000072861 | ClinicalTrials |
Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
Borderline Personality Disorder | 2 | D001883 | ClinicalTrials |
Fibromyalgia | 2 | D005356 | ClinicalTrials |
Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
Digestive System Diseases | 2 | D004066 | ClinicalTrials |
Stroke | 2 | D020521 | ClinicalTrials |
Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
Aphasia | 2 | D001037 | ClinicalTrials |
Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
Alzheimer Disease | 1 | D000544 | ClinicalTrials |
Hepatitis C | 1 | D006526 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 128196-01-0 |
ChEBI | 36791 |
ChEMBL | CHEMBL1508 |
DrugBank | DB01175 |
DrugCentral | 1053 |
EPA CompTox | DTXSID8048440 |
FDA SRS | 4O4S742ANY |
Human Metabolome Database | HMDB0005028 |
Guide to Pharmacology | 7177 |
PDB | 68P |
PharmGKB | PA10074 |
PubChem | 146570 |
SureChEMBL | SCHEMBL34948 |
ZINC | ZINC000003800706 |